Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KISS1R | Q969F8 | 14/20 | 0.67 |
| ▸ | IL1RN | P18510 | 2/20 | 0.64 |
| ▸ | ERAP2 | Q6P179 | 2/20 | 0.64 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29586130 | 0.93 | ERAP2 (0.68) | KISS1RIL1RNERAP2ERAP1 | |
| SCHEMBL31452846 | 0.92 | ERAP2 (0.70) | KISS1RIL1RNERAP2ERAP1 | |
| SCHEMBL31430944 | 0.90 | ERAP2 (0.69) | IL1RNERAP2ERAP1 | |
| SCHEMBL30949446 | 0.89 | KISS1R (0.63) | KISS1RIL1RNERAP2ERAP1 | |
| SCHEMBL29738146 | 0.88 | KISS1R (0.75) | KISS1R | |
| SCHEMBL15929992 | 0.88 | KISS1R (0.65) | KISS1R | |
| SCHEMBL30845356 | 0.88 | KISS1R (0.69) | KISS1R | |
| SCHEMBL11649947 | 0.88 | IL1RN (0.73) | KISS1RIL1RNERAP2ERAP1 | |
| SCHEMBL30845371 | 0.87 | KISS1R (0.71) | KISS1R | |
| SCHEMBL23314250 | 0.87 | KISS1R (0.68) | KISS1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240009331-A1 | UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR TARGETED RADIOLABELED PEPTIDE CONJUGATES | CURASIGHT A/S (DK) | 2024-01-11 | — | — | US | claimed |
| EP-4255506-A1 | UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR TARGETED RADIOLABELED PEPTIDE CONJUGATES | Curasight A/S (DK) | 2023-10-11 | — | — | EP | claimed |
| US-20230022032-A1 | uPAR-TARGETED PHOTOTHERMAL OPTICAL PROBES FOR PHOTOTHERMAL THERAPY | RIGSHOSPITALET (DK) | 2023-01-26 | — | — | US | claimed |
| US-20220401585-A1 | A UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR-TARGETING PEPTIDE | RIGSHOSPITALET (DK) | 2022-12-22 | — | — | US | claimed |
| EP-4081256-A1 | UPAR-TARGETED PHOTOTHERMAL OPTICAL PROBES FOR PHOTOTHERMAL THERAPY | Rigshospitalet (DK) | 2022-11-02 | — | — | EP | claimed |
| WO-2022117454-A1 | UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR TARGETED RADIOLABELED PEPTIDE CONJUGATES | RIGSHOSPITALET (DK) | 2022-06-09 | — | — | WO | claimed |
| CN-114555623-A | Urokinase plasminogen activator receptor targeting peptides | 丹麦国家医院 | 2022-05-27 | — | — | CN | claimed |
| EP-3999094-A1 | A UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR-TARGETING PEPTIDE | Rigshospitalet (DK) | 2022-05-25 | — | — | EP | claimed |
| EP-3999123-A1 | A RECEPTOR-TARGETING CONJUGATE WITH AN EFFECTIVE PHARMACOKINETIC PROFILE | Fluoguide A/S (DK) | 2022-05-25 | — | — | EP | claimed |
| US-20260077066-A1 | RECEPTOR-TARGETING CONJUGATE WITH AN EFFECTIVE PHARMACOKINETIC PROFILE | FLUOGUIDE AS | 2026-03-19 | — | — | US | disclosed |
| CN-114555623-B | Urokinase plasminogen activator receptor targeting peptides | 丹麦国家医院 | 2024-10-25 | — | — | CN | disclosed |
| US-20240009331-A1 | UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR TARGETED RADIOLABELED PEPTIDE CONJUGATES | CURASIGHT A/S (DK) | 2024-01-11 | — | — | US | disclosed |
| EP-4255506-A1 | UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR TARGETED RADIOLABELED PEPTIDE CONJUGATES | Curasight A/S (DK) | 2023-10-11 | — | — | EP | disclosed |
| US-20230022032-A1 | uPAR-TARGETED PHOTOTHERMAL OPTICAL PROBES FOR PHOTOTHERMAL THERAPY | RIGSHOSPITALET (DK) | 2023-01-26 | — | — | US | disclosed |
| US-20220401585-A1 | A UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR-TARGETING PEPTIDE | RIGSHOSPITALET (DK) | 2022-12-22 | — | — | US | disclosed |
| EP-4081256-A1 | UPAR-TARGETED PHOTOTHERMAL OPTICAL PROBES FOR PHOTOTHERMAL THERAPY | Rigshospitalet (DK) | 2022-11-02 | — | — | EP | disclosed |
| US-20220257799-A1 | A RECEPTOR-TARGETING CONJUGATE WITH AN EFFECTIVE PHARMACOKINETIC PROFILE | FLUOGUIDE A/S (DK) | 2022-08-18 | — | — | US | disclosed |
| WO-2022117454-A1 | UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR TARGETED RADIOLABELED PEPTIDE CONJUGATES | RIGSHOSPITALET (DK) | 2022-06-09 | — | — | WO | disclosed |
| CN-114555623-A | Urokinase plasminogen activator receptor targeting peptides | 丹麦国家医院 | 2022-05-27 | — | — | CN | disclosed |
| EP-3999094-A1 | A UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR-TARGETING PEPTIDE | Rigshospitalet (DK) | 2022-05-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230022032-A1 | uPAR-TARGETED PHOTOTHERMAL OPTICAL PROBES FOR PHOTOTHERMAL THERAPY | PLAUR, PLAU, PLG | KISS1R 2103/4885IL1RN 202/4885ERAP2 169/4885 |
| US-20220401585-A1 | A UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR-TARGETING PEPTIDE | PLAUR, PLAU, PLG | KISS1R 729/4885IL1RN 179/4885ERAP2 421/4885 |
| US-20260077066-A1 | RECEPTOR-TARGETING CONJUGATE WITH AN EFFECTIVE PHARMACOKINETIC PROFILE | FCGR2A, FCGR1A, FCGR3B | KISS1R 310/4885IL1RN 139/4885ERAP2 1698/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.